Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during mid-day trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The business’s 50-day simple moving average is C$0.08 and its 200 day simple moving average is C$0.06. The firm has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Using the MarketBeat Stock Split Calculator
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Airline Stocks – Top Airline Stocks to Buy Now
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- How Investors Can Find the Best Cheap Dividend Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
